Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Net Cash Flow (2010 - 2026)

Geron's (GERN) quarterly Net Cash Flow came in at -$6.1 million in Q2 2026, down 2.31% year-over-year from -$6.3 million in Q2 2025, and up 28.72% quarter-over-quarter from -$8.6 million in Q1 2026.

Analysis

Geron (GERN) Net Cash Flow (2010 - 2026) Analysis & Trends

Geron has disclosed Net Cash Flow across 17 years of filings, most recently posting -$6.1 million for Q2 2026.

  • In Q2 2026, Net Cash Flow fell 2.31% year-over-year to -$6.1 million; the TTM figure through Jun 2026 stood at -$15.0 million (up 61.04% YoY), while the FY2025 annual figure was -$1.5 million, down 115.62% from the prior year.
  • Net Cash Flow came in at -$6.1 million for Q2 2026 at Geron, up from -$8.6 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $119.8 million in Q1 2024 to a low of -$72.8 million in Q2 2024.
  • Average Net Cash Flow over 5 years is -$2.3 million, with a median of -$5.1 million recorded in 2022.
  • Year-over-year, Net Cash Flow soared 1677.36% in 2023 and slumped 282.89% in 2026.
  • Over 5 years, Net Cash Flow stood at -$4.3 million in 2022, then surged by 1034.68% to $39.9 million in 2023, then sank by 53.13% to $18.7 million in 2024, then plunged by 102.91% to -$544000.0 in 2025, then sank by 1030.15% to -$6.1 million in 2026.
  • Per Business Quant data, the three most recent Net Cash Flow figures were -$6.1 million in Q2 2026, -$8.6 million in Q1 2026, and -$544000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 1.95 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -4.43 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 652.90 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -504.30 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -183.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -496,000.00
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -2.09 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -170.75 Mn
10 Geron 914.60 Mn 613.75 Mn - -6.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.15 Mn
Mar 31, 2026 -8.63 Mn
Dec 31, 2025 -544,000.00
Sep 30, 2025 314,000.00
Jun 30, 2025 -6.01 Mn
Mar 31, 2025 4.72 Mn
Dec 31, 2024 18.71 Mn
Sep 30, 2024 -55.92 Mn
Jun 30, 2024 -72.79 Mn
Mar 31, 2024 119.75 Mn
Dec 31, 2023 39.91 Mn
Sep 30, 2023 -26.20 Mn
Jun 30, 2023 -55.71 Mn
Mar 31, 2023 55.95 Mn
Dec 31, 2022 -4.27 Mn
Sep 30, 2022 -14.96 Mn
Jun 30, 2022 -25.83 Mn
Mar 31, 2022 -3.55 Mn
Dec 31, 2021 5.84 Mn
Sep 30, 2021 -28.25 Mn